Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,268,176
  • Shares Outstanding, K 28,168
  • Annual Sales, $ 2,109 M
  • Annual Income, $ 404,390 K
  • EBIT $ 536 M
  • EBITDA $ 565 M
  • 60-Month Beta 1.42
  • Price/Sales 6.95
  • Price/Cash Flow 38.80
  • Price/Book 51.92

Options Overview Details

View History
  • Implied Volatility 58.90% (-1.41%)
  • Historical Volatility 29.03%
  • IV Percentile 92%
  • IV Rank 73.41%
  • IV High 70.52% on 04/11/25
  • IV Low 26.83% on 08/15/25
  • Expected Move (DTE 12) 56.51 (10.43%)
  • Put/Call Vol Ratio 1.95
  • Today's Volume 59
  • Volume Avg (30-Day) 43
  • Put/Call OI Ratio 1.77
  • Today's Open Interest 1,555
  • Open Int (30-Day) 1,481
  • Expected Range 485.53 to 598.55

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 4.18
  • Number of Estimates 4
  • High Estimate 4.35
  • Low Estimate 4.09
  • Prior Year 3.67
  • Growth Rate Est. (year over year) +13.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
538.29 +0.70%
on 02/05/26
628.92 -13.81%
on 01/16/26
-66.85 (-10.98%)
since 01/06/26
3-Month
530.96 +2.09%
on 12/04/25
628.92 -13.81%
on 01/16/26
-50.15 (-8.47%)
since 11/06/25
52-Week
250.05 +116.77%
on 04/22/25
628.92 -13.81%
on 01/16/26
+181.07 (+50.16%)
since 02/06/25

Most Recent Stories

More News
Earnings To Watch: Medpace (MEDP) Reports Q4 Results Tomorrow

Earnings To Watch: Medpace (MEDP) Reports Q4 Results Tomorrow

MEDP : 542.04 (+0.14%)
3 Market-Beating Stocks to Consider Right Now

3 Market-Beating Stocks to Consider Right Now

MEDP : 542.04 (+0.14%)
META : 661.46 (-1.31%)
AXON : 414.20 (+3.64%)
1 Volatile Stock with Solid Fundamentals and 2 We Avoid

1 Volatile Stock with Solid Fundamentals and 2 We Avoid

TER : 300.11 (+10.69%)
MEDP : 542.04 (+0.14%)
JBL : 258.25 (+6.79%)
2 Cash-Heavy Stocks with Promising Prospects and 1 We Find Risky

2 Cash-Heavy Stocks with Promising Prospects and 1 We Find Risky

MEDP : 542.04 (+0.14%)
WTS : 319.22 (+3.37%)
MMI : 26.60 (+3.10%)
Medpace (MEDP): Buy, Sell, or Hold Post Q3 Earnings?

Medpace (MEDP): Buy, Sell, or Hold Post Q3 Earnings?

MEDP : 542.04 (+0.14%)
2 Healthcare Stocks to Keep an Eye On and 1 We Ignore

2 Healthcare Stocks to Keep an Eye On and 1 We Ignore

MEDP : 542.04 (+0.14%)
GMED : 87.81 (+0.35%)
PRVA : 21.99 (+2.23%)
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2025 financial results after the market close on Monday, February 9, 2026. The...

MEDP : 542.04 (+0.14%)
1 Mid-Cap Stock with Competitive Advantages and 2 We Avoid

1 Mid-Cap Stock with Competitive Advantages and 2 We Avoid

MEDP : 542.04 (+0.14%)
DECK : 115.45 (+3.85%)
ZBRA : 251.40 (+4.28%)
1 Unpopular Stock That Deserves Some Love and 2 We Find Risky

1 Unpopular Stock That Deserves Some Love and 2 We Find Risky

MEDP : 542.04 (+0.14%)
NYT : 68.11 (-1.45%)
DXC : 15.20 (+7.12%)
2 Profitable Stocks to Keep an Eye On and 1 We Find Risky

2 Profitable Stocks to Keep an Eye On and 1 We Find Risky

MEDP : 542.04 (+0.14%)
HNI : 52.55 (+2.28%)
NVR : 8,009.84 (-0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

3rd Resistance Point 560.15
2nd Resistance Point 555.38
1st Resistance Point 548.71
Last Price 542.04
1st Support Level 537.28
2nd Support Level 532.51
3rd Support Level 525.84

See More

52-Week High 628.92
Last Price 542.04
Fibonacci 61.8% 484.19
Fibonacci 50% 439.48
Fibonacci 38.2% 394.78
52-Week Low 250.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar